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Abstract
OBJECTIVE: To examine the efficacy of Korean red
ginseng for improving blood flow in healthy
people.
METHODS: Participants were randomized and
treated with 1500 mg of Korean red ginseng
extract or placebo for 8 weeks. The effect of Korean
red ginseng was evaluated by digital infrared
thermal images, and Doppler sonography, and
blood test.
RESULTS: Forty subjects completed the protocol.
Imbalance in local thermal distribution was
significantly decreased in the Korean red ginseng
group confirmed by digital infrared thermal
images. Doppler sonography showed no significant
change in maximum and average rates of blood
circulation in single or complex areas. Blood
analyses for coagulation and lipid metabolism
factors revealed no significant changes. No
abnormal reactions to the Korean red ginseng were
observed.
CONCLUSION: Digital infrared thermal imaging
showed that the temperature deviation in the
whole body decreased safely in the Korean red
ginseng group, which mitigated the body-
temperature imbalance. This result suggests that
the Korean red ginseng improves blood circulation
in the human body.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Korean red ginseng (the steamed root of Panax
ginseng) is a well-known traditional medicinal remedy
used in Asian countries as well as in the United States
and Europe.1,2 Korean red ginseng is prepared by
steaming or otherwise heating the root with skins
intact and subsequently drying. In the course of the
steaming process, ginseng starch is gelatinized, causing
an increase in saponin content. Traditionally, Korean
red ginseng has been used to restore and enhance
normal well-being and is often referred to as an
adaptogenic.3 Active constituents found in most
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ginseng species include ginsenosides, polysaccharides,
peptides, polyacetylenic alcohols, and fatty acids.
Recent studies have reported that the major active
ingredients such as ginsenosides have antioxidant,
antiinflammatory,4,5 antiapoptosis,6 anticancer,7,8
antiallergic,9,10 and hematopoietic effects.11,12 A major
compound of Korean red ginseng, ginsenoside-Rb1,
has been reported to improve blood circulation by
functioning as a calcium antagonist.13
The Korean population is predicted to be an "aging"
society by 2018 and a "super-aging" society by 2026.14
As the population age, the incidence of vascular disease
increases. Because vascular diseases can present serious
health problems, early diagnosis and prevention are
becoming more important.15,16 Although, recent studies
have investigated the efficacy of Korean red ginseng on
blood circulation, most studies have been observational
and of low quality.17,18
The aim of this study was to elucidate the effect of
Korean red ginseng on blood circulation including
blood coagulation time, blood-flow velocity, and local
thermal distribution in a randomized, double-blind
clinical trial.
MATERIALS ANDMETHODS
Trial design
This study was designed as a randomized, double-
blind, placebo-controlled, parallel group trial. This
study was approved by the Institutional Review Board
of Cheonan Oriental Hospital of Daejeon University
and conducted in accordance with the ethical
standards for human experimentation established by
the Declaration of Helsinki.19
Participants
Participants were recruited by outdoor and homepage
advertising sponsored by Cheonan Oriental Hospital.
Subjects were required to be in satisfactory health and
free from any significant disease. Volunteers (aged
30-50 years) were eligible for participation. Excluded
from this study were subjects with cholesterol levels
over 240 mg/dl; those with diabetes mellitus,
hypertension, or with blood coagulation problems;
those with a history of taking blood circulation agents
or antioxidative agents within 3 weeks; and those who
were currently pregnant or were planning to become
pregnant in the near future. All the procedures
associated with this study were conducted at the
clinical trial center at Cheonan Oriental Hospital of
Daejeon University.
Sample size
Based on a previous study,18 the difference in activated
partial thromboplastin time (aPPT) was estimated to
be 5 min with a standard deviation (SD) of 5. Sample
size was calculated by the sample-size parameters for
80% statistical power at a 5% significance level. The
predicted drop-out rate was 20% , and the calculated
sample size was 20 subjects per group.
Intervention
Participants received one ginseng capsule (500 mg)
manufactured by Korea Tobacco and Ginseng (KTNG,
Daejeon, Republic of Korea) or one placebo three
times per day for 8 weeks. In terms of composition,
Korean red ginseng main root comprises 70% of
ginseng capsules and Korean red ginseng lateral root
comprise 30% . The placebo material was carefully
prepared to match the appearance, volume, weight,
color, flavor, and taste of ginseng and consisted of a
capsule containing starch (95.25% ), artificial Korean
red ginseng flavor (4%), natural coloring agent (0.15%),
and caramel color (0.6%).
Randomization
To conceal the identity of the group to which subjects
were assigned, participants were randomized centrally.
Assignment to one of the two parallel treatment groups
(20 in each) was performed by a statistician using a
randomization program. The two groups were
randomized by blocks of four.
Trial protocol
Subjects were scheduled to visit the clinical trial center
three times. On the first visit, participants consent and
medical history were collected. On the second visit (1
week later), laboratory tests, digital infrared thermal
imaging (DITI), and Doppler sonography were
performed, and sufficient study drugs for 8 weeks were
given. On the third visit (8 weeks later), the tests
performed during the second visit were repeated.
Compliance and adverse events were monitored three
times between the second and third visits by telephone.
Outcome measurment
Efficacy was assessed by laboratory tests related to
blood coagulation (prothrombin time; PT and
activated partial thromboplastin time; aPTT), lipid
profiles (total cholesterol, low-density lipoprotein
cholesterol, high-density lipoprotein cholesterol,
triglycerides) and DITI, as well as by Doppler
sonography. Safety was assessed by laboratory blood
tests [blood urea nitrogen (BUN), aspartate
aminotransferase (AST), alanine aminotransferase
(ALT), creatinine], urine tests [specific gravity (SG),
glucose, nitrite, bilirubin, blood, red blood cells
(RBC), white blood cells (WBC), and ketones], and
adverse-effect monitoring.
DITI and Doppler sonography
Before and after administration of Korean red ginseng,
temperatures of the whole body (face, trunk, and both
upper and lower limbs) were measured with the DITI
System, IRIS-XP (Medicore, Korea) in a temperature-
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controlled dark room maintained at around 19℃-
21℃ . A 10-mm circle of local temperatures was
measured in both zygomata, forehead, center of the
sternum, abdomen, torso, both palms, shin, and dorsa
of both feet. Subjects sat quietly in front of the
machine for 15 min before the DITI was taken. They
were directed to refrain from smoking within 2 h of
the DITI, and not to drink alcohol, bathe, undergo
physical therapy or heliotherapy, or receive an
electromyogram within a day before the DITI.
Doppler sonographic examinations were performed
with a Vasodop VD 1000 (ELCAT, Germany) using
4-, 2- and 8-MHz probes in a multidirectional
ultrasound probe-holder construction. The opthalmic
artery was identified through the orbital window, with
the flow direction normally toward the probe, about
50 mm from the skull surface. The vertebral artery
was insonated between 70-80 mm with the probe
through the suboccipital window. The internal carotid
artery was isonated through the submandibular
window. The radial artery was identified 1 cm from the
wrist joint, and the dorsal artery of foot was isonated
around the extensor hallucis.20,21
Adverse events monitoring
All subjects were monitored for adverse events
(including adverse drug reactions and onset of
illnesses) during the study. All adverse events were
forwarded in a blind fashion to the primary
investigator to be rated as mild, moderate, or severe.
The physician graded the severity of adverse events as
mild (present, but did not interfere with the ability to
carry out duties or require medical intervention),
moderate (some interference with daily duties and
required no or minimal medical therapy), and severe
(daily duties could not be completed and required
medical intervention or hospitalization). The
relationship between the study drug and adverse events
were recorded as certain, probable/likely, possible,
unlikely, unrelated, and unassessable/unclassifiable.
Monitoring adverse events was performed during the
study period by telephone call and physical
examination.
Statistical methods
Statistical analyses were performed using a modified
intent-to-treat (ITT) analysis as outlined in the
original study protocol. Data were compared by
independent t-tests. Differences at the level of P<0.05
were regarded as statistically significant. Data
processing and analyses were performed with SPSS for
Windows, version 12 (SPSS Inc., Japan).
RESULTS
Participant flow
We identified 42 volunteers from August 20, 2010 to
October 20, 2010. Forty-two subjects were screened,
and two declined to participate after receiving the
study information. After excluding the two subjects,
we randomly assigned 40 volunteers who met our
inclusion criteria to the Korean red ginseng (n=20) and
placebo (n=20) groups (Figure 1) Compliance was
verified at over 80% for 30 participants and at
70%-80% for the remaining participants. No adverse
events were recorded throughout the study period.
Demographic characteristics
Baseline demographic characteristics of the study
subjects are presented in Table 1. The parameters
before treatment were not significantly different
between the two groups.
Blood coagulation and lipid profiles
We found no statistically significant differences
Assessed for eligibility (n=42)
Excluded (n=2)
Not meeting inclusion criteria (n=0)
Declined to participate (n=2)
Other reasons (n=2)
Randomized (n=40)
Placebo (n=20)
Completed the protocol (n=20)
Analyzed (n=20)
Ginseng oral administration (n=20)
Comleted the ptotocol (n=20)
Analyzed (n=20)
Figure 1 Flow diagram of selection
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between the two groups with respect to pre-and
post-study laboratory tests for blood coagulation and
lipid profiles. Although the aPTT and PT values were
prolonged in the Korean red ginseng group, this
difference did not reach statistical significance (data
not shown).
DITI
The body temperatures of the groups did not
differ before the study (all P>0.05) (Table 2). The
temperature of the abdomen increased significantly in
the Korean red ginseng group (35.1℃ ± 0.6℃ )
compared with that in the placebo group (34.6℃ ±
1.0℃ ) (P=0.044<0.05). Local temperatures of the
zygomata, forehead, palms, dorsa of the feet, and
center of the sternum did not differ between the two
groups (Table 3). A comparison of forehead and
abdomen temperatures [Δ(temperature of forehead－
temperature of abdomen)] revealed a significant
difference in the Korean red ginseng (-0.61℃ ±
0.51℃ ) and placebo (0.03℃ ± 0.67℃ ) groups (P=
0.002<0.05). The whole body and forehead
temperatures [Δ(temperature of whole body －
temperature of forehead)] were significantly higher in
the Korean red ginseng group (-0.21℃ ± 0.49℃ than
in the placebo group (0.57℃ ± 0.56℃ ) (P=0.041<
0.05). Administration of Korean red ginseng vs
placebo was not associated with a statistically
significant difference in the temperature differences
observed between abdomen and palms, dorsa of the
feet, and limbs [Δ(temperature of abdomen －
temperature of palms, dorsa of feet, and limbs)] (all
P>0.05). Similarly, we found no statistically
significant differences between the groups with
respect to differences between whole body
temperature and temperatures of palms, dorsa of the
feet, and limbs [Δ (temperature of whole body －
temperature of palms, dorsa of feet, and limbs) ] (all
P>0.05) (Tables 4).
Doppler sonography
Values representing the peak systolic flow and mean
flow velocity in the Korean red ginseng group were
higher than those in the placebo group, although these
differences did not reach statistical significance (all P>
0.05) (Table 5, 6). Comparisons of differences in the
mean flow velocities of the whole blood vessel (WBV)
and basilar artery, vertebral artery, dorsal artery of the
foot, and popliteal artery did not reflect any significant
differences (all P>0.05) (Table 7).
Safety assessment
Laboratory tests of AST, ALT, BUN, and creatinine
did not show any hepatotoxicity or nephrotoxicity.
Urinalyses of SG, glucose, ketone, nitrite, bilirubin,
blood, RBC, and WBC did not reveal any abnormal
results. No adverse events were observed throughout
the study period.
Body part
Right zygoma
Left zygoma
Right palm
Left palm
Right shin
Left shin
Center of sternum
Abdomen
Torso
Right dorsum of foot
Left dorsum of foot
Forehead
Korean red Ginseng
34.9±1.0
34.8±1.0
35.3±0.8
35.1±0.8
34.8±0.5
34.8±0.5
35.7±0.6
35.0±0.9
35.3±0.5
33.0±1.6
33.0±1.4
36.4±0.4
Placebo
34.9±0.7
34.8±0.8
34.9±1.3
34.7±1.4
34.7±0.5
34.7±0.5
35.8±0.5
35.0±0.8
35.4±0.6
33.0±1.4
32.9±1.3
36.3±0.3
P value
0.965
0.859
0.277
0.243
0.396
0.309
0.642
0.860
0.617
0.948
0.820
0.648
Table 2 Body part temperatures before administration in the
two groups (℃, xˉ ±s)
Body part
Right zygoma
Left zygoma
Right palm
Left palm
Right shin
Left shin
Center of sternum
Abdomen
Torso
Right dorsum of foot
Left dorsum of foot
Forehead
Korean red Ginseng
34.1±0.8
34.0±0.9
34.0±1.6
34.1±1.7
34.4±0.5
34.3±0.5
35.9±0.5
35.1±0.6
35.3±0.4
31.1±1.5
31.2±1.2
35.9±0.6
Placebo
34.1±1.2
34.0±1.4
33.2±1.9
33.2±1.8
34.2±0.4
34.1±0.6
35.6±0.7
34.6±1.0
35.0±0.7
30.9±1.7
30.8±1.6
35.9±0.5
P value
0.891
0.903
0.212
0.105
0.222
0.198
0.139
0.044a
0.103
0.646
0.319
0.677
Table 3 Body part temperatures after administration in the
two groups (℃, xˉ ±s)
Note: aP<0.05 by independent t-test.
Group
Korean red Ginseng
Placebo
n
20
20
Male (n)
9
8 (46%)
Female (n)
11
12 (54%)
Age (year)
38±6
42±5
Height (cm)
163±8
161±8
Weight (kg)
64±11
62±10
Table 1 Demographic characteristics of the subjects ( xˉ ±s)
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Temperature difference
Abdomen－Palma
Abdomen－Dorsum of footb
Abdomen－Limbc
Whole body－Palmd
Whole body－Dorsum of foote
Whole body－Limbf
Korean red
Ginseng
1.3±1.5
1.9±1.6
1.6±1.6
0.5±1.5
1.1±1.6
0.8±1.6
Placebo
1.2±1.5
1.7±1.7
1.4±1.4
0.6±1.0
1.1±1.3
0.9±0.8
P value
0.813
0.657
0.670
0.627
0.910
0.662
Table 4 Temperature differences of specific parts before and
after administration in the two groups (℃, xˉ ±s)
Notes: aTemperature difference between abdomen and palm
temperatures after administration－difference before
administration. bTemperature difference between abdomen and
dorsum of foot temperatures after administration－difference
before administration. cTemperature difference between
abdomen and limb temperatures after administration－
difference before administration. dDifference between whole
body and palm temperatures after administration－difference
before administration. eTemperature difference between whole
body and dorsum of foot temperatures after administration－
difference before administration. fTemperature difference
between whole body and limb temperatures after
administration－difference before administration.
DISCUSSION
The purpose of our study was to investigate the
efficacy and safety of Korean red ginseng for improving
blood flow using DITI and Doppler ultrasonography.
Previous studies focused only on the relationship
between Korean red ginseng and anti-coagulation.16,17
Thus, we measured the flow velocities of the arteries as
well as the body-temperature distribution after Korean
red ginseng administration using DITI and Doppler
ultrasonography.
The clinical utility of transcranial Doppler (TCD)
ultrasonography in cerebrovascular disease has been
extended recently. Although a number of studies have
defined normal reference values of TCD measurements,
these studies have several limitations, including their
use of a relatively small number of subjects and a lack
of data regarding some cerebral vessels and/or
parameters.22 Recently, many studies examining the
effects of acupuncture and herbs on brain blood flow
have used Doppler ultrasonography.23
Thermal imaging is a non-contact, non-invasive
diagnostic method for studying human bodily
Blood artery
BA
Right VA
Left VA
Right QA
Left OA
Right ICA
Left ICA
Right RA
Left RA
Right DA
Left DA
Right PA
Left PA
Korean red Ginseng
59±20
51±19
50±14
86±17
75±14
54±12
59±18
44±21
38±17
28±19
25±17
23±08
23±07
Placebo
65±15
50±14
43±12
80±18
76±22
52±10
54±11
40±17
36±14
26±16
25±17
21±05
21±05
P value
0.351
0.925
0.072
0.332
0.805
0.658
0.308
0.556
0.602
0.634
0.935
0.381
0.399
Table 5 Peak systolic flow velocity after administration in the
two groups (cm/s, xˉ ±s)
Notes: BA:basilar artery; VA: vetebral artery; OA: ophthalmic
artery; ICA: internal carotid artery; RA: radial artery; DA:dorsal
artery of foot; PA: popliteal artery.
Blood artery
BA
Right VA
Left VA
Right siphon
Left siphon
Right ICA
Left ICA
Right RA
Left RA
Right DA
Left DA
Right PA
Left PA
Korean red Ginseng
38±12
32±11
33±08
56±11
48±10
34±11
36±12
20±09
18±07
15±10
13±08
13±04
12±04
Placebo
42±10
33±09
29±08
53±14
50±14
32±06
34±09
20±10
16±06
12±07
14±08
12±03
11±03
P value
0.269
0.874
0.094
0.426
0.589
0.371
0.443
0.986
0.414
0.368
0.702
0.163
0.292
Table 6 Mean flow velocity after administration in the two
groups (cm/s, xˉ ±s)
Notes: BA:basilar artery; VA: vetebral artery; OA: ophthalmic
artery; ICA: internal carotid artery; RA: radial artery; DA:dorsal
artery of foot; PA: popliteal artery.
WBV–BA
WBV–VA
WBV–DA
WBV–PA
WBV–RA
Korean red Ginseng
-10±11
-04±08
16±04
15±07
10±07
Placebo
-14±07
-03±04
16±05
15±06
10±07
P value
0.111
0.581
0.714
0.963
0.989
Table 7 Differences in the mean flow velocity of blood
vessels after administration in the two groups (cm/s, xˉ ±s)
Notes: WBV: whole blood vessel; BA: basilar artery; VA: vasilar
artery; DA: dorsal artery of foot; PA: popliteal artery; RA: radial
artery.
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temperatures.24 Thermography can be applied as a
diagnostic tool in many clinical applications, including
oncology, allergic diseases, angiology, plastic surgery,
and rheumatology.25-27 Moreover, the body-temperature
distribution in peripheral circulatory disturbances can
be measured using DITI.28
We found that administration of Korean red ginseng
did not affect PT or aPTT. Our results do not support
a previous study that reported the efficacy of Korean
red ginseng for prolonging aPTT.18 Further clinical
trials are needed to investigate the effect of Korean red
ginseng on blood coagulation in blood-circulatory-
disturbed subjects.
No significant changes were found in Doppler
ultrasonography, possibly because we used healthy
subjects. In the DITI study, we found that Korean red
ginseng treatment increased only local temperatures of
the abdomen. It has been suggested that taking Korean
red ginseng remedies can cause fever or headache
because of the thermal-stimulating effect of Korean red
ginseng on the face or forehead. However, we conclude
that no scientific linkage between Korean red ginseng
treatment and headache or flushing of the face exists.
Korean red ginseng administration significantly reduced
the temperature difference between the forehead and
abdomen and between the whole body and forehead.
Therefore, Korean red ginseng treatment improved the
unbalanced thermal distribution. Laboratory blood tests,
urinalyses, and adverse-events monitoring demonstrated
the safety ofKorean red ginseng.
We showed that Korean red ginseng did not influence
blood coagulation or blood flow velocity but improved
body temperature distribution. This result links the
preventative effect of Korean red ginseng with
improvement in the homeostasis of healthy people.
Further studies are needed to research the effect of
Korean red ginseng on blood-circulatory disturbances
in disease settings.
ACKNOWLEDGEMENTS
This work was supported by the 2010 grant from the
Korean Society of Ginseng funded by Korea Ginseng
Corporation.
REFERENCES
1 Bae EA, Trinh HT, Yoon HK, Kim DH. Compound K. A
metabolite of ginsenoside Rb1, inhibits passive cutaneous
anaphylaxis reaction in mice. J Ginseng Res 2009; 33(2):
93-98.
2 Ro JY, Ahn YS, Kim KH. Inhibitory effect of ginsenoside
on the mediator release in the guinea pig lung mast cells
activated by specific antigen-antibody reactions. Int J
Immunopharmacol 1998; 18(2): 625-641.
3 Coon JT, Ernst E. Panax ginseng: a systematic review of
adverse effects and drug interactions. Drug Safety 2002; 25
(5): 323-44.
4 Kim JY, Kim HJ, Kim HJ. Effect of oral administration
of korean red ginseng on influenza a (H1N1) virus
infection. J Ginseng Res 2011; 35(1): 104-110.
5 Park S, Yeo M, Jin JH, et al. Inhibitory activities and
attenuated expressions of 5-LOX with red ginseng in
Helicobacter pylori-infected gastric epithelial cell. Dig Dis
Sci 2007; 52(4): 973-982.
6 Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician
2003; 68(8): 1539-1542.
7 Helms S. Cancer prevention and therapeutics: Panax
ginseng. Altern Med Rev 2004; 9(3): 259-274.
8 Fishbein AB, Wang CZ, Li XL, et al. Asian ginseng
enhances the anti-proliferative effect of 5-fluorouracil on
human colorectal cancer: comparison between white and
red ginseng. Arch Pharm Res 2009; 32(4): 505-513.
9 Park HJ, Jung DH, Joo H, et al. The comparative study
of anti-allergic and anti-inflammatory effects byfermented
red ginseng and red ginseng. Korean J Plant Resour 2010;
23(5): 415-422.
10 Jung JW, Kang HR, Ji GE, et al. Therapeutic effects of
fermented red ginseng in allergic rhinitis: a randomized,
double-blind, placebo-controlled study. Allergy Asthma
Immunol Res 2011; 3(2): 103-110.
11 Buettner C, Yeh GY, Phillips RS, Mittleman MA,
Kaptchuk TJ. Systematic review of the effects of ginseng
on cardiovascular risk factors. Ann Pharmacother 2006; 40
(1): 83-95.
12 Joo SS, Won TJ, Kim MS, Lee DI. Hematopoietic effect
of ginsenoside Rg3 in ICR mouse primary cultures and its
application to a biological response modifier. Fitoterapia
2004; 75(3-4): 337-341.
13 Fujita K, Hakuba N. Ginsenoside Rb1 protects against
damage to the spiral ganglion cells after cochlear ischemia.
Neurosci Lett 2007; 415(2): 113-117.
14 Kim JY, Jeon YS, Cho SG, et al. Prevalence and
characteristics of major vascular diseases of elderly men in
the incheon area. J Korean Surg Soc 2010; 78: 305-313.
15 Alzamora MT, Forés R, Baena-Díez JM, et al. The
peripheral arterial disease study (PERART/ARTPER):
prevalence and risk factors in the general population.
BMC Public Health 2010; 10: 38.
16 Kim JY, Jeon YS, Cho SG, et al. Prevalence and
characteristics of major vascular diseases of elderly men in
the incheon area. J Korean Surg Soc 2010; 78(5):
305-313.
17 Sin KS, Lee JJ. Effect of korean red ginseng extract on
blood circulation in healthy volunteers: a randomized,
double-blind, placebo-controlled trial. J Ginseng Res
2007; 31(2): 109-116.
18 Lee JH, Park HJ. Effects of intaking of red ginseng
products on human platelet aggregation and blood lipids.
J Ginseng Res 1998; 22(3): 173-180.
19 WMA Declaration of Helsinki - Ethical principles for
44
Kang JH et al. / Clinical Study
JTCM |www. journaltcm. com February 15, 2013 |volume 33 | Issue 1 |
medical research involving human subjects. Available from
URL: http://www.wma.net/en/30publications/10policies/
b3/index.html
20 Han BI. Cerebral blood flow ultrasonography. Pureunso.
Seoul;, 2004.
21 Moore KL, Dalley AF. Clinically oriented anatomy. 5th
ed. Seoul: Shinheung Med Scienc; 2007.
22 Kim GW, Sohn YH, Lee SM, et al. The reference values
and influencing factors of TCD measurements in 200
normal Korean adults. J Korean Neurol Assoc 1995; 13
(4): 815-824.
23 Shin YM, Hyuk B, Jung CY, et al. The use of transcranial
doppler (tcd) in korean medicin, a review. J Korean
Acupunct Moxibust Soc 2010; 27(3): 83-92.
24 Song BY. Clinical predictive diagnostic study on
prognosis of Bell`s palsy with the Digital Infrared Thermal
Image. J Korean Acupunct Moxibust Soc 2001; 18(1):
1-13.
25 Kim MJ, Lee SY, Kim SH, et al. Evaluation of the
therapeutic effects in pain management using infrared
thermal imaging. J Korean Pain Soc 2001; 14(2): 164-170.
26 De Weerd L, Mercer JB, Weum S. Dynamic infrared
thermography. Clin Plast Surg 2011; 38(2): 277-292.
27 Song C, Appleyard V, Murray K, et al. Thermographic
assessment of tumor growth in mouse xenografts. Int J
Cancer 2007; 121(5): 1055-1058.
28 Kim HB. Study on infrared thermography. J Korean Acad
Orthop Man Phys Ther 1995; 1(1): 9-14.
Contact persons
Congress office
event lab. GmbH
Dufourstraße 15, 04107 Leipzig, Germany
S +49 (0)3 41 24 05 96-55
T +49 (0)3 41 24 05 96-51
U office@tcm-kongress.de
Congress President
Gerd Ohmstede
Eupener Straße 176, 52066 Aachen, Germany
U ohmstede@tcm-kongress.de
Chairman of the congress
Christian Yehoash
Weichselstraße 16, 10247 Berlin, Germany
U yehoash@tcm-kongress.de
Congress centre
Evangelische Tagungsstätte Wildbad
Taubertalweg 42, 91541 Rothenburg o. d. T., Germa-
ny
Organiser
agtcm e. V.
Arbeitsgemeinschaft für Klassische Akupunktur und
Traditionelle
Chinesische Medizin e. V.
President: Nils von Below
www.agtcm.de
Further Information
www.tcm-kongress.de
h
45
